\
&
Contact us
\
&
Contact us
Published on | 1 hour ago
Programmes Digital, Industry & SpaceThe EuroHPC Joint Undertaking (EuroHPC JU) has launched a new call for proposals inviting European quantum computing startups to develop integrated hardware–software quantum computing solutions with strong market potential.
The call will be implemented in two phases:
The call for Phase 1 closes on 8 January 2026. Applications for Phase 1 must be submitted via the EU Funding & Tenders Portal. More details can be found on this dedicated webpage.
After the completion of Phase 1, participants will directly apply to the EIB Venture Debt Platform to receive financing under Phase 2.
More information can be found on the EuroHPC JU's website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Research Infrastructures Horizon Europe Digital Europe
Building on the revised Charter for access to research infrastructures , this new Charter will be specifically aimed at facilitating access of companies. It will make it easier for companies, especially small and medium-sized businesses (SMEs), startups and scaleups, to access Europe’s world-class research and technology... read more
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
